FNY Investment Advisers’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

FNY Investment Advisers’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$6K	–	819
2022 Q4	$6K	Sell	1,000 -2,000	-67%	-$11.1K	0.01%	353
2022 Q3	$15K	Buy	3,000 +1,000	+50%	+$6.28K	0.01%	351
2022 Q2	$12K	Buy	+2,000	New	+$6.74K	0.01%	397

FNY Investment Advisers's FSTX Position: Q1 2023 in Review

FNY Investment Advisers sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 1,000 shares — an estimated $6K sold.

FNY Investment Advisers first reported a position in FSTX in Q2 2022 and held it in 3 quarters. The position peaked at $15K in Q3 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

FNY Investment Advisers reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
FNY Investment Advisers sold 1,000 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $6K.
FNY Investment Advisers first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
FNY Investment Advisers's F-star Therapeutics, Inc. Common Stock position peaked at $15K in Q3 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on FNY Investment Advisers's 13F filing for Q1 2023, filed 12 Apr 2023.